LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency

By LabMedica International staff writers
Posted on 05 Feb 2025
Image: The iTLA Max total laboratory automation system on display at Medlab Middle East 2025 (Photo courtesy of YHLO)
Image: The iTLA Max total laboratory automation system on display at Medlab Middle East 2025 (Photo courtesy of YHLO)

YHLO (Shenzhen, China) is presenting iTLA Max, its total laboratory automation system designed to enhance laboratory workflows and optimize performance.

YHLO's independently developed iTLA MAX laboratory automation system is designed to address practical issues in medical laboratories, integrating innovative technology into every aspect of laboratory work, from pre-analysis to analysis and post-analysis, achieving comprehensive intelligent connectivity. It plays a significant role in improving clinical laboratory testing efficiency, enhancing departmental management capabilities, and advancing the development of laboratory science. The iTLA MAX laboratory automation system is composed of units such as sampling, centrifugation, capping, rack connection, track, and output, offering unprecedented convenience and efficiency in sample processing through its intelligent and efficient modular design. The 360-degree ring light design ensures that laboratory personnel can observe the equipment's operating status from any angle, providing strong support for laboratory safety management. The waterfall-style screen design, combined with ergonomic standards, adjusts the screen height to ensure user comfort during operation. The intelligent information management system integrates multiple functions such as operation control, data processing, alarm prompts, and query statistics, providing laboratory personnel with an intuitive and convenient interface.

YHLO’s iFlash series chemiluminescence immunoassay analyzers, highly acclaimed in the industry for their exceptional accuracy and rapid processing speed, were prominently featured at the exhibition. In addition to its leading self-immunity diagnostic products, YHLO highlighted its new biochemistry-immunoassay integrated analyzer along with a comprehensive suite of over 100 testing assays. As a major player in China’s IVD industry, YHLO offers a wide array of testing solutions covering self-immunity, infectious disease, reproductive health, liver disease, respiratory conditions, and cardiovascular diagnostics, among others. The new integrated analyzer provides laboratories with more flexible testing options.

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Homocysteine Quality Control
Liquichek Homocysteine Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more